Clinical trials: Metastatic Skin Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma

Treatment With Nab-paclitaxel in Cutaneous SCC

• Terminated
• Age: 18 years and older
• Phase 2
• Results posted

This is an investigator initiated phase II study to assess the efficacy of a chemotherapy called nab-paclitaxel as first line cytotoxic chemotherapy in subjects with unresectable locally advanced or metastatic cutaneous squamous…

Trial name

NCT02076243

Testing

nab-paclitaxel

Where

United States

Volunteers

2 people

Sponsor

Icahn School of Medicine at Mount Sinai